BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15769646)

  • 1. Hepatitis B virus X antigen (HBxAg) and cell cycle control in chronic infection and hepatocarcinogenesis.
    Feitelson MA; Reis HM; Liu J; Lian Z; Pan J
    Front Biosci; 2005 May; 10():1558-72. PubMed ID: 15769646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.
    Feitelson MA; Duan LX
    Am J Pathol; 1997 Apr; 150(4):1141-57. PubMed ID: 9094970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis.
    Lian Z; Liu J; Wu M; Wang HY; Arbuthnot P; Kew M; Feitelson MA
    Hepatology; 2007 Jun; 45(6):1390-9. PubMed ID: 17539024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B x antigen and p53 in the development of hepatocellular carcinoma.
    Feitelson MA
    J Hepatobiliary Pancreat Surg; 1998; 5(4):367-74. PubMed ID: 9931385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of p38MAPK and HBxAg on cell proliferation and apoptosis in human hepatocarcinogenesis].
    Shen LJ; Guo W; Gao P; Yu J; Qian ZY; Zhang HX; Zhang ZJ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):227-30. PubMed ID: 22475145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma.
    Liu J; Lian Z; Han S; Waye MM; Wang H; Wu MC; Wu K; Ding J; Arbuthnot P; Kew M; Fan D; Feitelson MA
    Oncogene; 2006 Feb; 25(7):1008-17. PubMed ID: 16247464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of hepatitis B virus X antigen expression with liver cell apoptosis].
    Li C; Wang YK; Wang CY; DU L; Zhang XH; Dong GF
    Zhonghua Gan Zang Bing Za Zhi; 2013 Apr; 21(4):252-6. PubMed ID: 24021784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
    Wang WL; London WT; Feitelson MA
    Cancer Res; 1991 Sep; 51(18):4971-7. PubMed ID: 1654208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.
    Wang XZ; Chen XC; Chen YX; Zhang LJ; Li D; Chen FL; Chen ZX; Chen HY; Tao QM
    World J Gastroenterol; 2003 Dec; 9(12):2671-5. PubMed ID: 14669310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.
    Tufan NL; Lian Z; Liu J; Pan J; Arbuthnot P; Kew M; Clayton MM; Zhu M; Feitelson MA
    Neoplasia; 2002; 4(4):355-68. PubMed ID: 12082552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cellular gene up-regulated by hepatitis B virus-encoded X antigen promotes hepatocellular growth and survival.
    Lian Z; Liu J; Pan J; Satiroglu Tufan NL; Zhu M; Arbuthnot P; Kew M; Clayton MM; Feitelson MA
    Hepatology; 2001 Jul; 34(1):146-57. PubMed ID: 11431746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of fibronectin gene expression by hepatitis B virus x antigen.
    Norton PA; Reis HM; Prince S; Larkin J; Pan J; Liu J; Gong Q; Zhu M; Feitelson MA
    J Viral Hepat; 2004 Jul; 11(4):332-41. PubMed ID: 15230856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of monoclonal antibody directed against hepatitis B virus X protein and detection of reactive antigen in hepatocellular carcinoma].
    Li J; Tang ZY; Liu KD; Schroder CH
    Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):533-5, 582. PubMed ID: 7842349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.
    Feitelson MA; Reis HM; Tufan NL; Sun B; Pan J; Lian Z
    Cancer Lett; 2009 Dec; 286(1):69-79. PubMed ID: 19201080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomas.
    Greenblatt MS; Feitelson MA; Zhu M; Bennett WP; Welsh JA; Jones R; Borkowski A; Harris CC
    Cancer Res; 1997 Feb; 57(3):426-32. PubMed ID: 9012469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.
    Zhang X; Dong N; Yin L; Cai N; Ma H; You J; Zhang H; Wang H; He R; Ye L
    J Med Virol; 2005 Nov; 77(3):374-81. PubMed ID: 16173017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin.
    Lian Z; Liu J; Li L; Li X; Clayton M; Wu MC; Wang HY; Arbuthnot P; Kew M; Fan D; Feitelson MA
    Hepatology; 2006 Mar; 43(3):415-24. PubMed ID: 16496348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas using anti-HBxAg monoclonal antibody.
    Pál J; Somogyi C; Szmolenszky A A; Szekeres G; Sípos J; Hegedüs G; Martzinovits I; Molnár J; Németh P
    Pathol Oncol Res; 2001; 7(3):178-84. PubMed ID: 11692143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of hepatitis B virus-related hepatocellular carcinoma].
    Zhang Y; Guo J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):152-6. PubMed ID: 26983488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.